Bil Vyapar Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of BIL Vyapar Ltd is ₹ 6.3 as of 13 Mar 15:30 . The P/E Ratio of BIL Vyapar Ltd changed from 4.7 on March 2025 to 4.7 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of BIL Vyapar Ltd changed from ₹ 88.86 crore on March 2023 to ₹ 31.87 crore on March 2025 . This represents a CAGR of -28.95% over 3 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of BIL Vyapar Ltd for the Dec '25 is ₹ 0.23 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of BIL Vyapar Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 ebitda of ₹ -0.81 crore. This represent the decline of -107% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of BIL Vyapar Ltd changed from ₹ 8.17 crore to ₹ 0.06 crore over 7 quarters. This represents a CAGR of -93.97% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of BIL Vyapar Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About BIL Vyapar Ltd

BIL Vyapar Limited, formerly known as Binani Industries Limited was established in 1962.
The name of the Company was changed to BIL Vyapar Limited from Binani Industries Limited w.e.f. 04th June, 2025.
The Company was promoted by Binani Metals in technical and financial collaboration with Cominco, Canada with the name Cominco Binani Zinc.
Global Composites Holdings Inc is the Subsidiary Company of the BIL Vyapar Limited. The Braj Binani Group made a humble beginning in the metals business in 1872, when Seth Pragdas Binani, a trader in metal utensils started an enterprise with his son Seth Mathuradas to import and export ferrous and non-ferrous metals.
This enterprise grew stronger and bigger when Seth Mathuradas' son Seth Govardhandas took a bold step to move from trading to manufacturing.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of BIL Vyapar Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, BIL Vyapar Ltd or Genomic Valley Biotech Ltd?

Market cap of BIL Vyapar Ltd is 20 Cr while Market cap of Genomic Valley Biotech Ltd is 7 Cr

What are the key factors driving the stock performance of BIL Vyapar Ltd and Genomic Valley Biotech Ltd?

The stock performance of BIL Vyapar Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BIL Vyapar Ltd and Genomic Valley Biotech Ltd?

As of March 13, 2026, the BIL Vyapar Ltd stock price is INR ₹6.61. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹25.13.

How do dividend payouts of BIL Vyapar Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of BIL Vyapar Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.